Literature DB >> 18602168

Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma.

Frederik G Dikkers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602168     DOI: 10.1016/j.ijporl.2008.05.013

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


× No keyword cloud information.
  3 in total

1.  Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir.

Authors:  Leslie Castelo-Soccio; Ronald Bernardin; John Stern; Stephen A Goldstein; Carrie Kovarik
Journal:  Arch Dermatol       Date:  2010-02

2.  The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.

Authors:  S Mikolajczak; G Quante; S Weissenborn; A Wafaisade; U Wieland; J C Lüers; J P Klussmann; D Beutner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-06       Impact factor: 2.503

3.  Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.

Authors:  Małgorzata Wierzbicka; Joanna Jackowska; Anna Bartochowska; Agata Józefiak; Witold Szyfter; Witold Kędzia
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-26       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.